Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Session R.A. II Create: Alert

All | News | Filings
Date FiledTypeDescription
07/14/2023 4 Session R.A. II (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Sold 80,528 shares @ $0.7082, valued at $57k
Sold 5,344 shares @ $0.7, valued at $3.7k
03/08/2023 4 Session R.A. II (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Acquired 251,296 shares @ $0
Disposed/sold 199,500 options to buy @ $1.95, valued at $389k
12/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2022 4 Session R.A. II (President and CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Granted 217,850 options to buy @ $5.96, valued at $1.3M
12/08/2021 4 Session R.A. II (President and CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Bought 16,510 shares @ $12.12, valued at $200.1k
Bought 26,008 shares @ $12.65, valued at $329k
01/20/2021 4 Session R.A. II (President and CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns: Granted 199,700 options to buy @ $31, valued at $6.2M
10/05/2020 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
09/23/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
04/27/2020 3 Session R.A. II (Director) has filed a Form 3 on Chardan Healthcare Acquisition 2 Corp.
05/15/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2018 4 Session R.A. II (Sr. VP, Corp Strategy) has filed a Form 4 on AveXis, Inc.
Txns: Granted 1,667 shares @ $0
Granted 6,572 options to buy @ $133.8, valued at $879.3k
05/12/2017 4 Session R.A. II (Sr. VP, Corp Strategy) has filed a Form 4 on AveXis, Inc.
Txns: Granted 1,282 options to buy @ $77.24, valued at $99k
03/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/23/2017 3 Form 3 - Initial statement of beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy